Maria Sandstrom
Umea, AC, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
MGMT promoter methylation status for glioblastoma: defining the clinically relevant cut-off value for pyrosequencing.
Journal: Journal of neuro-oncology
Published: April 22, 2026
Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey.
Journal: European journal of endocrinology
Published: February 07, 2026
Characterizing long- and short-survival glioblastoma patients with FLT-PET/MRI and metabolomics.
Journal: Neuro-oncology advances
Published: May 05, 2025
The impact of socioeconomic status on glioma survival: a retrospective analysis.
Journal: Cancer causes & control : CCC
Published: December 06, 2024
Antidepressants and survival in glioma-A registry-based retrospective cohort study.
Journal: Neuro-oncology practice
Published: March 18, 2024
Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
Journal: International journal of cancer
Published: August 04, 2023
Antidepressant drugs and risk of developing glioma: a national registry-based case-control study and a meta-analysis.
Journal: American journal of epidemiology
Published: July 06, 2023
Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: December 30, 2022
Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study.
Journal: Langenbeck's archives of surgery
Published: June 28, 2022
Distinct metabolic hallmarks of WHO classified adult glioma subtypes.
Journal: Neuro-oncology
Published: February 14, 2022
Last Updated: 09/26/2026